Formaldehyde → HCID 25124329, compound
Reaction equation
[CH:1]1([N:6]2[CH2:12][C:11]([CH3:14])([CH3:13])[C:10](=[O:15])[N:9]([CH3:16])[C:8]3[CH:17]=[N:18][C:19]([NH:21][C:22]4[CH:34]=[CH:33][C:25]([C:26]([NH:28][CH:29]5[CH2:32][NH:31][CH2:30]5)=[O:27])=[CH:24][C:23]=4[O:35][CH3:36])=[N:20][C:7]2=3)[CH2:5][CH2:4][CH2:3][CH2:2]1.C=O.[C:39]([BH3-])#N.[Na+].C([O-])(O)=O.[Na+]>CO.Cl>[CH:1]1([N:6]2[CH2:12][C:11]([CH3:13])([CH3:14])[C:10](=[O:15])[N:9]([CH3:16])[C:8]3[CH:17]=[N:18][C:19]([NH:21][C:22]4[CH:34]=[CH:33][C:25]([C:26]([NH:28][CH:29]5[CH2:32][N:31]([CH3:39])[CH2:30]5)=[O:27])=[CH:24][C:23]=4[O:35][CH3:36])=[N:20][C:7]2=3)[CH2:2][CH2:3][CH2:4][CH2:5]1Participants
Procedure
4-(9-cyclopentyl-6,7,8,9-tetrahydro-5,7,7-trimethyl-6-oxo-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-N-(azetidin-3-yl)-3-methoxybenzamide (69 mg, 0.14 mmol) was dissolved in methanol (1.5 ml). 37% aqueous formaldehyde (66 μl, 0.84 mmol) and sodium cyanoborohydride (26 mg, 0.42 mmol) were successively added. The reaction mixture was stirred at room temperature for 2 hours. The crude mixture was diluted with 2N HCl then, basified with a saturated solution of NaHCO3. The mixture was extracted twice with ethyl acetate. The combined organic phases were dried (MgSO4 and concentrated in vacuo. The title compound (33 mg) was obtained as a white solid after crystallization from ethyl acetate. NMR DMSO D6 1.10 (6H, s), 1.55-1.69 (4H, m), 1.69-1.80 (2H, m), 1.82-1.95 (2H, m), 2.28 (3H, s), 3.01 (2H, t), 3.38 (2H, s), 3.57 (2H, t), 3.95 (3H, s), 4.39-4.50 (1H, m), 5.12-5.25 (1H, m), 7.43-7.52 (2H, m), 7.71 (1H, s), 8.00 (1H, s), 8.38 (1H, d), 8.63 (1H, d); HPLC rt(min): 9.60; MS (ES+) 508, (ES−) 506.
Workup
- extractionThe mixture was extracted twice with ethyl acetate
- dry with materialThe combined organic phases were dried (MgSO4
- concentrationconcentrated in vacuo
Sources & evidence
- ORD record
- ord-d8730ee4ea6843d0b6ab00f60d3e7489
- Source dataset
- uspto-grants-2011_09
- Patent number
- US08022202B2
Reaction notes
Loading…